StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) shareholders

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
15.1%
12M of 80M shares
Institutional holders
62
20 new, 3 sold out
Net institutional buying
10M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of NGENValueChange% of portfolio
Empery Asset Management, LP4,000,0005.02%$8.24MNew9.53%
Rock Springs Capital Management LP1,208,2311.52%$2.49MNew0.12%
DAFNA Capital Management LLC1,050,0001.32%$2.16MNew0.41%
Ghisallo Capital Management LLC1,000,0001.26%$2.06MNew0.04%
Armistice Capital, LLC678,0000.85%$1.40MNew0.02%
LMR Partners LLP600,0000.75%$1.24MNew0.00%
Marshall Wace, Llp435,9620.55%$898.08K+235,6030.00%
UBS Group AG379,7260.48%$782.24K+318,2090.00%
Stonepine Capital Management, LLC271,6780.34%$559.66KNew0.32%
Jane Street Group, LLC270,7500.34%$557.75KNew0.00%
Woodline Partners LP250,5000.31%$516.03KNew0.00%
PFG Investments, LLC217,5000.27%$448.05K+16,5000.02%
Bank Of America Corp /De/186,2000.23%$383.57K−14,4560.00%
Royal Bank of Canada176,0750.22%$363.00K+4,1140.00%
Quadrature Capital Ltd134,5180.17%$277.11KNew0.00%
Bank Of Montreal /Can/78,3940.10%$284.38K+15,4940.00%
Integrated Wealth Concepts LLC74,2150.09%$152.88K−12,6000.00%
Captrust Financial Advisors64,4230.08%$132.71K+2,0560.00%
Geode Capital Management, LLC58,0400.07%$119.56KNew0.00%
Osaic Holdings, Inc.51,0930.06%$105.25K+11,1020.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20266212M15.1%20 / 207 / 310M0M
Q1 2026452M2.1%44 / 00 / 02M0M
Q4 202510M0.0%1 / 00 / 00M0M
Q2 202400M0.0%0 / 00 / 10M0M
Q1 202410M0.0%0 / 00 / 00M0M
Q4 202310M0.0%0 / 00 / 00M0M
Q3 202310M0.0%0 / 00 / 00M0M
Q2 202310M0.0%0 / 00 / 00M0M
Q1 202310M0.0%0 / 00 / 00M0M
Q4 202210M0.0%0 / 00 / 00M0M
Q3 202210M0.0%0 / 00 / 10M0M
Q2 202220M0.0%0 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

1 funds held NGEN in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of NGENValue% of fundAs of
Fidelity Nasdaq Composite Index Fund15,3620.02%$31.80K0.00%May 31, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
5M shares short
Days to cover
11.2
At 0M shares a day
Change since last report
-4.4%
From 5M shares
Short volume, 20 days
46.5%
Of volume reported to FINRA

Shares sold short, last 10 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NervGen Pharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,910 shares on Sep 8, 2026 over the last 90 days.

See a number that looks wrong?